| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M112215200 |
| P698 | PubMed publication ID | 11823467 |
| P2093 | author name string | Li Zhong | |
| Changqing Zhao | |||
| Debra F Skafar | |||
| Janice A Schwartz | |||
| Sarah Deighton-Collins | |||
| P2860 | cites work | Helix capping | Q24673351 |
| Estrogen receptor transcription and transactivation: Basic aspects of estrogen action | Q24800814 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS | Q26778400 | ||
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
| The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
| Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists | Q33888199 | ||
| State of the arg: protein methylation at arginine comes of age. | Q34084396 | ||
| The PROSITE database, its status in 1997. | Q34622236 | ||
| Positive cooperativity of the estrogen receptor | Q35460526 | ||
| Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites | Q38307076 | ||
| An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity | Q38313711 | ||
| Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. | Q38328418 | ||
| Sequence determinants of the capping box, a stabilizing motif at the N-termini of alpha-helices | Q41825033 | ||
| Phosphorylation of serine-46 in HPr, a key regulatory protein in bacteria, results in stabilization of its solution structure. | Q41959152 | ||
| Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation. | Q42614325 | ||
| The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists | Q42826611 | ||
| Conformational preferences of amino acids in globular proteins | Q44870543 | ||
| GOR method for predicting protein secondary structure from amino acid sequence. | Q52319038 | ||
| An algorithm for protein secondary structure prediction based on class prediction. | Q52591620 | ||
| Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. | Q54160126 | ||
| Influence of N-cap mutations on the structure and stability of Escherichia coli HPr. | Q54581092 | ||
| Structural consequences of histidine phosphorylation: NMR characterization of the phosphohistidine form of histidine-containing protein from Bacillus subtilis and Escherichia coli. | Q54622046 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13202-13209 | |
| P577 | publication date | 2002-01-31 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen | |
| P478 | volume | 277 |
| Q37134877 | An F-domain introduced by alternative splicing regulates activity of the zebrafish thyroid hormone receptor alpha |
| Q34272156 | Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. |
| Q39022052 | Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators. |
| Q36797684 | General molecular biology and architecture of nuclear receptors |
| Q33521519 | Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. |
| Q35024939 | Molecular Basis of Steroid Action in the Prostate |
| Q47140933 | Molecular mechanism of estrogen-estrogen receptor signaling |
| Q40409904 | Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens |
| Q45291310 | Role of regulatory F-domain in hepatocyte nuclear factor-4alpha ligand specificity |
| Q52584533 | Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. |
| Q88310809 | The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation |
| Q36598699 | The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy |
| Q37117655 | The multifunctional estrogen receptor-alpha F domain |
| Q92315527 | Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor α Ligand Binding Domain |
Search more.